EPHA2 and ovarian cancer: Nishimura et al. demonstrated sandwich RNAi inhibition by targeting the important ovarian cancer oncogene, EphA2, using a combination of EphA2-targeting siRNAs and miR-520d-3p (an EphA2-targeting miRNA) mimics.